Vor Biopharma VOR Faces Q1 2026 Headwinds Earnings Come in Below Views Telomir Pharmaceuticals TELO Q4 2025 Miss What Went Wrong Nvidia to Establish Singapore Research Hub as CityState Accelerates Physical AI Initiatives